Research published in the New England Journal of Medicine finds that the hospital pay-for-performance program adopted in England did not lead to sustained improvement in mortality rates.
Read More
The new health insurance exchange policies don't offer particularly high levels of coverage, as revealed in a report funded by the Robert Wood Johnson Foundation.
Read More
Solvadi is the first of a new group of wonder drugs for Hepatitis C, but its cost is staggering. A brief by Milliman examines the impact of the drug on…
Read More
There is so much talk about patient engagement that it is worth thinking more carefully about what that means and what it really means for costs and quality.
Read More
After the first wave of reform law mandated insurance signups, a substantial number of Americans remain uninsured. An Urban Institute brief describes the characteristics of this still-uninsured population.
Read More
A study published by the National Bureau of Economic Research finds that, at least in regard to Medicare spending, patient demands are relatively unimportant but physician beliefs about treatment account…
Read More
The small group insurance market covers about 19 million Americans. A Mark Farrah Associates report describes the current state of the market.
Read More
An Agency for Healthcare Research & Quality Statistical Brief gives us data on inpatient hospital costs and utilization from 2003 and 2013 and a projection about the future.
Read More
The New England Journal of Medicine carries a thoughtful article on FDA regulation of "mobile health" technologies.
Read More
A paper sponsored by the American Federation of Hospitals explores the apparent contrast between falling rates of health spending growth and increased health costs for consumers.
Read More
After discussing private health insurance exchanges yesterday, today we look into a few recent issues on the public exchanges.
Read More
A brief Accenture report describes the rapid growth in private health insurance exchanges and the factors behind that growth.
Read More
Studies in the Journal of the American Medical Association look at the evidence behind FDA approval of new drugs and at the reasons for delay or denials of approval.
Read More
A brief from the Kaiser Family Foundation looks at out-of-pocket spending by Medicare Beneficiaries, including premiums and service cost-sharing. For some seniors, these numbers are pretty large.
Read More
The Government Accounting Office reviews drug spending for DOD, Medicare and Medicaid; finding that Medicaid generally paid the lowest prices, in some cases substantially lower.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.